90 results
DEFA14A
ONCR
Oncorus, Inc.
3 Aug 23
Additional proxy soliciting materials
4:38pm
Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks
8-K
ONCR
Oncorus, Inc.
3 Aug 23
Departure of Directors or Certain Officers
4:36pm
Private Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends
DEFA14A
ONCR
Oncorus, Inc.
28 Jul 23
Additional proxy soliciting materials
4:40pm
harbor provisions of the United States Private Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates
8-K
ONCR
Oncorus, Inc.
28 Jul 23
Departure of Directors or Certain Officers
4:12pm
Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may
PRE 14A
2ghba34a0
12 Jun 23
Preliminary proxy
6:33am
8-K
x69qfzs
7 Jun 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-99.1
9wgd3
1 Jun 23
Oncorus Announces Workforce Reduction Plan
4:34pm
8-K
EX-99.1
bi2ovda7oe5q1
22 May 23
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
4:13pm
8-K
lyqcv0q3l8o
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
8-K
EX-99.1
e4w145e5e
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
8-K
EX-99.1
04f7x20mz20wu1
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
8-K
EX-99.1
3vzt3gn4ze
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
8-K
EX-99.1
gdqr1x8g3msshqh6c
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am